Angiology: Open Access
Open Access

Atherosclerosis: The Role of Inflammation and Lipid Metabolism

Cynthia Georgia^{* *}Correspondence: Cynthia Georgia, Department of Cardiology, Başkent University, Ankara, Turkey, Email:

Author info »

Description

Atherosclerosis is a chronic inflammatory disease characterized by the buildup of plaques within arterial walls, leading to narrowing and stiffening of blood vessels. This condition is a major contributor to cardiovascular diseases, including coronary artery disease, stroke, and peripheral artery disease. Understanding the complex interactions between inflammation and lipid metabolism is crucial for elucidating the pathogenesis of atherosclerosis and developing effective therapeutic strategies.

Pathogenesis of atherosclerosis

Atherosclerosis begins with endothelial dysfunction, which allows the infiltration of lipids, immune cells, and inflammatory mediators into the arterial intima,the innermost layer of the arterial wall. Key steps in the pathogenesis include:

Endothelial activation and dysfunction: Endothelial cells normally maintain vascular homeostasis by regulating vascular tone and permeability. Various risk factors such as hypertension, hyperlipidemia, and smoking can disrupt endothelial function, leading to increased expression of adhesion molecules and chemokines that promote the process of circulating monocytes.

Lipid accumulation and foam cell formation: Low-Density Lipoprotein (LDL) particles penetrate the damaged endothelium and accumulate in the arterial intima. LDL undergoes modification, becoming oxidized LDL (oxLDL), which is highly pro-inflammatory and cytotoxic. Macrophages within the intima engulf oxLDL, transforming into foam cells.

Inflammatory response and plaque formation: Foam cells release cytokines, chemokines, and growth factors that amplify local inflammation and attract additional immune cells, including T lymphocytes. These cells perpetuate inflammation, contributing to the progression of atherosclerotic plaques characterized by a lipid-rich necrotic core and a fibrous cap.

Role of inflammation in atherosclerosis

Inflammation plays a pivotal role throughout all stages of atherosclerosis, from initiation to plaque destabilization and rupture. Key inflammatory mediators and pathways include:

Cytokines and chemokines: Pro-inflammatory cytokines such as Interleukin-1 (IL-1), Interleukin-6 (IL-6), and Tumor Necrosis Factor-alpha (TNF-alpha) promote endothelial activation, leukocyte activation, and foam cell formation.

Oxidative stress: Oxidative stress resulting from the imbalance between Reactive Oxygen Species (ROS) and antioxidant defenses enhances LDL oxidation and triggers inflammatory responses within the arterial wall.

Immune cell activation: Macrophages and T lymphocytes release Matrix Metalloproteinases (MMPs) that degrade extracellular matrix proteins, weakening the fibrous cap of atherosclerotic plaques and increasing the risk of rupture and thrombosis.

Lipid metabolism in atherosclerosis

Dysregulation of lipid metabolism, particularly elevated levels of LDL cholesterol and triglycerides, contributes significantly to the pathogenesis of atherosclerosis:

LDL cholesterol: LDL particles transport cholesterol from the liver to peripheral tissues. Excess LDL accumulates in the arterial intima, initiating the formation of fatty streaks and promoting atherosclerotic plaque development.

HDL cholesterol: High-Density Lipoprotein (HDL) particles transport cholesterol from peripheral tissues back to the liver for excretion, a process known as reverse cholesterol transport. HDL exhibits anti-inflammatory and antioxidant properties, contributing to its protective role against atherosclerosis.

Lipoprotein (Lp(a)): Elevated levels of Lp(a), a cholesterol-rich lipoprotein similar to LDL, are associated with increased cardiovascular risk. Lp(a) promotes atherosclerosis by promoting LDL retention within arterial walls and impairing endothelial function.

Diagnostic approaches

Accurate diagnosis and risk stratification of atherosclerosis involve a combination of clinical assessment, laboratory tests, and imaging modalities:

Lipid profile: Measurement of total cholesterol, LDL cholesterol, HDL cholesterol, and triglyceride levels provides insights into lipid metabolism and cardiovascular risk.

Ultrasound: Carotid Intima-media Thickness (CIMT) measurement assesses early-stage atherosclerosis in carotid arteries.

Computed Tomography (CT) angiography: Visualizes coronary artery calcification and evaluates the extent of coronary artery disease.

Intravascular Ultrasound (IVUS) and Optical Coherence Tomography (OCT): High-resolution imaging modalities for assessing plaque morphology and vulnerability.

Therapeutic strategies

Management of atherosclerosis aims to reduce cardiovascular risk factors, stabilize plaques, and prevent complications are

Lifestyle modifications: Including dietary changes, regular exercise, smoking cessation, and weight management to optimize lipid profiles and reduce inflammation.

Statins: Inhibit cholesterol synthesis and promote LDL receptor expression, reducing LDL cholesterol levels and stabilizing atherosclerotic plaques.

Antiplatelet agents: Aspirin and P2Y12 inhibitors prevent thrombus formation and reduce the risk of acute coronary events.

Anti-inflammatory therapies: Emerging therapies targeting specific inflammatory pathways (IL-1 inhibition) show promise in reducing cardiovascular risk beyond traditional lipid-lowering strategies.

Conclusion

Future research in atherosclerosis will focus on identifying novel therapeutic targets, exploring the role of genetic factors and microbiota in disease pathogenesis, and optimizing personalized treatment approaches. Advances in precision medicine and therapeutic interventions hold potential for mitigating the global burden of cardiovascular diseases associated with atherosclerosis, emphasizing the importance of integrated strategies that address both inflammation and lipid metabolism. As scientific understanding continues to evolve, the pursuit of effective preventive and therapeutic strategies remains most important in combating this pervasive cardiovascular condition.